Intravenous Nalbuphine for Prevention of Intrathecal Morphine-induced Nausea and Vomiting in Patients Undergoing Cesarean Section: A Double-blind, Randomized Controlled Trial.
Clinical trial NCT06837129 · COMPLETED
Trial details
- NCT number
- NCT06837129
- Sponsor
- Thammasat University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-15
- Primary completion
- 2025-02-15
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.